Themis Medicare Limited (THEMISMED.BO)
INR 273.3
(0.64%)
INR 273.3
(0.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 199.46 Million | 160.92 Million | 343.94 Million | 569.75 Million | 3.28 Million | 109.23 Million |
| Net Income | 435.23 Million | 725.14 Million | 952.62 Million | 413.3 Million | 268.74 Million | -125.97 Million |
| Depreciation & Amortization | 122.46 Million | 104.94 Million | 94.79 Million | 85.47 Million | 82.72 Million | 79.9 Million |
| Deferred income taxes | - | - | - | - | - | -34.23 Million |
| Stock-based compensation | - | - | - | - | - | 549 Thousand |
| Change in working capital | -178.81 Million | -402.96 Million | -425.52 Million | 79.03 Million | -356.34 Million | 70.77 Million |
| Other non-cash items | 338.46 Million | -266.21 Million | -277.94 Million | -8.06 Million | 8.16 Million | 118.21 Million |
| Investing Cash Flow | -183.93 Million | -239.61 Million | -155.85 Million | -156.51 Million | -54.66 Million | -37.23 Million |
| Investments in PPE | -184.17 Million | -287.47 Million | -206.27 Million | -180.38 Million | -58.06 Million | -56.34 Million |
| Acquisitions | 249 Thousand | 340 Thousand | 13.22 Million | 475 Thousand | 365 Thousand | 1.58 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 24.69 Million | 47.52 Million | 37.18 Million | 23.4 Million | 3.03 Million | 17.53 Million |
| Financing Cash Flow | -11.42 Million | 1.36 Million | -175.46 Million | -256.47 Million | 67.24 Million | -99.39 Million |
| Debt repayment | -38.36 Million | -134.06 Million | -66.06 Million | -196.85 Million | -175.6 Million | -26.42 Million |
| Dividends payments | -46.01 Million | -46 Million | -39.55 Million | -16.07 Million | - | - |
| Common Stock Repurchased | - | 268.12 Million | - | -43.69 Million | - | - |
| Common Stock Issuance | 415 Thousand | 837 Thousand | 3.95 Million | 155 Thousand | 2.36 Million | - |
| Other Financing Activities | -80.46 Million | -87.53 Million | -73.8 Million | 1000.00 | 240.49 Million | -72.96 Million |
| Accounts receivables | -329.21 Million | -444.61 Million | -229.53 Million | 248.74 Million | -286.93 Million | -51.63 Million |
| Accounts payables | 72.47 Million | 81.7 Million | 10.81 Million | 11.08 Million | -53.57 Million | 44.84 Million |
| Inventory | -16.22 Million | -81.42 Million | -23.15 Million | -38.85 Million | -9.74 Million | -40.59 Million |
| Other working capital | 94.15 Million | 41.36 Million | -183.66 Million | -141.94 Million | -6.1 Million | 118.17 Million |
| Cash at beginning of period | 188.82 Million | 202.79 Million | 190.18 Million | 33.41 Million | 17.54 Million | 44.93 Million |
| Cash at end of period | 192.96 Million | 125.46 Million | 202.79 Million | 190.18 Million | 33.41 Million | 17.54 Million |
| Capital Expenditure | -184.17 Million | -287.47 Million | -206.27 Million | -180.38 Million | -58.06 Million | -56.34 Million |
| Effect of forex changes on cash | - | - | - | - | -1000.00 | - |
| Net cash flow / Change in cash | 4.13 Million | -77.32 Million | 12.61 Million | 156.76 Million | 15.86 Million | -27.38 Million |
| Free Cash Flow | 15.28 Million | -126.55 Million | 137.66 Million | 389.36 Million | -54.78 Million | 52.88 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 435.23 Million | 73.68 Million | 113.19 Million | 181.92 Million | 725.14 Million | 84.05 Million |
| Depreciation & Amortization | 122.46 Million | 30.95 Million | 30.7 Million | 30.25 Million | 104.94 Million | 27.96 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -178.81 Million | - | - | - | -402.96 Million | - |
| Other non-cash items | 338.46 Million | -30.95 Million | -30.7 Million | -30.25 Million | -266.21 Million | -27.96 Million |
| Investing Cash Flow | -183.93 Million | - | - | - | -239.61 Million | - |
| Investments in PPE | -184.17 Million | - | - | - | -287.47 Million | - |
| Acquisitions | 249 Thousand | - | - | - | 340 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 47.52 Million | - |
| Financing Cash Flow | -11.42 Million | - | - | - | 1.36 Million | - |
| Debt repayment | -38.36 Million | - | - | - | -134.06 Million | - |
| Dividends payments | -46.01 Million | - | - | - | -46 Million | - |
| Common Stock Repurchased | - | - | - | - | 268.12 Million | - |
| Common Stock Issuance | 415 Thousand | - | - | - | 837 Thousand | - |
| Other Financing Activities | - | - | - | - | -87.53 Million | - |
| Accounts receivables | -329.21 Million | - | - | - | -444.61 Million | - |
| Accounts payables | 72.47 Million | - | - | - | 81.7 Million | - |
| Inventory | -16.22 Million | - | - | - | -81.42 Million | - |
| Other working capital | 94.15 Million | - | - | - | 41.36 Million | - |
| Cash at beginning of period | 188.82 Million | 223.83 Million | 110.63 Million | 188.82 Million | 202.79 Million | 104.76 Million |
| Cash at end of period | 192.96 Million | 73.68 Million | 223.83 Million | 181.92 Million | 125.46 Million | 188.82 Million |
| Capital Expenditure | -184.17 Million | - | - | - | -287.47 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.13 Million | -150.15 Million | 113.19 Million | -6.89 Million | -77.32 Million | 84.05 Million |
| Free Cash Flow | 15.28 Million | 73.68 Million | 113.19 Million | 181.92 Million | -126.55 Million | 84.05 Million |
BNL
6549
7839
SEB
IMMX
ZODIAC